Compare CPRI & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPRI | OMCL |
|---|---|---|
| Founded | 1981 | 1992 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Computer Manufacturing |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 1.9B |
| IPO Year | 2011 | 2000 |
| Metric | CPRI | OMCL |
|---|---|---|
| Price | $16.67 | $46.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | $26.62 | ★ $55.83 |
| AVG Volume (30 Days) | ★ 2.5M | 703.6K |
| Earning Date | 05-27-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 111.40 | N/A |
| EPS | ★ 1.14 | 0.25 |
| Revenue | ★ $3,474,000,000.00 | $787,309,000.00 |
| Revenue This Year | N/A | $6.77 |
| Revenue Next Year | $1.81 | $5.22 |
| P/E Ratio | ★ $15.32 | $186.20 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $16.72 | $26.85 |
| 52 Week High | $28.27 | $51.84 |
| Indicator | CPRI | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 33.66 | 64.64 |
| Support Level | N/A | $43.34 |
| Resistance Level | $22.08 | $51.62 |
| Average True Range (ATR) | 0.82 | 2.07 |
| MACD | -0.26 | 0.61 |
| Stochastic Oscillator | 0.18 | 89.60 |
Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. John Idol has served as Capri's CEO since 2003.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.